PRAGMATIST: A DECISION SUPPORT TOOL FOR FOOT AND MOUTH DISEASE VACCINE BANK MANAGERS

Similar documents
The Global FMD situation: SEACFMD in the Global Context

Global FMD Surveillance and Regional Risks for West Eurasia

Keith Sumption Secretary, European FMD Control Commission (EuFMD) FAO, Rome

The global control of FMD; challenges and opportunities

Role of the EuFMD/European countries - West EurAsia and other Regional Roadmaps

FMD regional update Gulf States 2017

Pillar 2: Reduce Risk to members from the FMD Situation in the European Neighbourhood Accomplishments and Lessons Learned

Overview of WRL FMD. Historical perspective. Principal activities. FMD threats. Needs/prospects. David Paton

Global Update EuFMD Exec. Committee

Toward the control of Foot-and-Mouth disease in East Asia

Global Update. EuFMD Exec. Committee. Donald King

Dr Ghazi Yehia OIE Regional Representative for the Middle East

Emma Fishbourne. FMD and SVD Reference Laboratories

Open to: Model developers and users with an interest in the objective

Foot and Mouth Disease Middle East situation Summary of Answers to the Questionnaire Beirut, Lebanon, 7 9 April 2009

FMD Vaccine Strain Selection

FMD Progressive Control Pathway. Peter de Leeuw, DVM, PhD

The Progressive Control Pathway (PCP) for FMD control

16 th JPC REMESA meeting

OIE/FAO Global Conference on foot and mouth disease. The way towards global control. Paraguay: 24 to 26 June Draft Resolution version 8

O 38% NVD 42% A 10% Asia 1 9% SAT2 1% SAT1 <1% Institute for Animal Health

Foot and mouth disease control strategies in North Africa and the Middle East the current

The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group

WRLFMD Global update. Donald King

Regional FMD threats to North Africa

Keith Sumption Secretary, European FMD Control Commission (EuFMD) FAO, Rome

Update from WRLFMD Donald King

Regional Status and FMD s Control Strategies in North Africa

FMD Progressive Control Pathway (PCP-FMD)

Update from WRLFMD. Donald King

Global FMD Surveillance Report

Progress on Implementation of Global FMD Control

Myanmar Disease Surveillance & Monitoring

Analysis of the Worldwide FMD Situation Trends and Regional Differences

Vision for the West Asia Roadmap for FMD Control

WEST EURASIA FMD LAB PHASE ACTIVITY PROPOSAL. A. Naci BULUT Head of the Diagnosis Department, Şap Institute

Paper on needs and support to be provided to North African countries, members of REMESA regarding the coordinated control of FMD

Summary Report of Activities/Missions conducted since April 2011, with planned activities into (K.Sumption)

Title of the presentation: The FMD virus. Subtitle: Virus Pool 6, Southern Africa. pools and Regional programs. Name Surname: Misheck Mulumba et al

Scientific Opinion on sheep pox and goat pox - first part

Standing Technical Committee Report

PROGRESS REPORT FOR TURKEY ON FMD SITUATION AND CONTROL MEASURES

Unique features of foot and mouth disease in Southern Africa

The Progressive Control Pathway for FMD control (PCP-FMD)

Development and Current Situation FMD for Asia and the Pacific

OIE Situation Report for Avian Influenza

Appendix 5. The challenge. Virus pools and Regional Roadmaps. The Progressive Control Pathway PCP) for FMD control PCP-FMD

Scientists, representatives of Veterinary

FMD in Libya. Dr. Abdunaser Dayhum National Center of Animal Health Libya

FMD VIRUS POOL 4- EASTERN AFRICA

OIE Situation Report for Highly Pathogenic Avian Influenza

FMD CONTROL IN KYRGYZSTAN State Inspectorate for Veterinary and Phyto- Sanitary Security under the Government of the Kyrgyz Republic

OIE Situation Report for Highly Pathogenic Avian Influenza

Vision for the West Asia Roadmap for FMD Control

FMD VACCINES AND THEIR USE IN VACCINATION PROGRAMMES: THEORY AND PRACTICE

FMD Eradication Dreaming Peter Windsor Peter Windsor DVSc Specialist Veterinary Surgeon (Pathobiology, Small Ruminant Health Management)

FMD Carrier state and role of carrier buffalo as source of transboundary spread in Southeast Asia and Eastern Asia Satya Parida

Final Report 1 6th West Eurasia FMD Roadmap, Almaty / Kazakhstan, April 2015

FMD in Southern Africa

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

OIE Situation Report for Highly Pathogenic Avian Influenza

This CRP is proposed for five years with three RCM. To apply, please see our website for directions:

Foot-and-Mouth Disease Situation Monthly Report July 2016

Is my vaccination programme working? Vaccine effectiveness: measuring vaccine protection in the field

REPORT ON THE SITUATION OF FMD IN TURKEY

Foot and mouth disease situation and control strategies in the People s Republic of China the current situation

PCP Stage 1 focus: To gain an understanding of the epidemiology of FMD in the country and develop a risk-based approach to reduce the impact of FMD

Importance of Vaccines for Managing FMD

REGIONAL REFERENCE LABORATORY FOR FMD IN SOUTH EAST ASIA DEPARTMENT OF LIVESTOCK DEVELOPMENT PAKCHONG, NAKHONRATCHASIMA, THAILAND

Update on current global situation for FMD: New outbreaks and threats

FMD Report - Syria 6 th Regional FMD West Eurasia Roadmap Meeting - Almaty, Kazakhstan 28 to 30 April 2015

FMD VACCINE AND VACCINATION. Ahmad Al-Majali Dean, Faculty of Vet Medicine JUST Jordan

FMD in Tunisia Update situation Critical review Vaccination programme

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report. October 2017

Day 1. Global Overview: Dr Don King, WRLFMD

West Eurasia Regional Roadmap Meeting Country Presentation 2012

Preparation of the global

The work of the WRLFMD in relation to regional networks. Reference Laboratory for FMDV

WHEN FMD GOES WILD LINKING ECOLOGY, EPIDEMIOLOGY AND SURVEILLANCE. Sergei Khomenko, Tsviatko Alexandrov, Naci Bulut, Sinan Aktas, Keith Sumption

THE EuFMD COMMISSION, : A DECADE OF DEVELOPMENT

SEACFMD ACTIVITIES FOCUS ON

ANALYSIS OF THE ANIMAL HEALTH SITUATION IN MEMBER COUNTRIES IN THE REGION DURING 2015 AND 2016

The New FMD Containment Zone Proposal and Vaccination. April 4, 2017, Pirenopolis, Brazil

Pirbright and ISZLER. EuFMD Open Session 2018

Foot-and-Mouth Disease Situation Monthly Report January 2017

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

FMD diagnostics: current developments and application in the context of FMD control in endemic countries Wilna Vosloo

Manufacturers expected contribution to the progressive control of Foot-and-Mouth Disease in South Asia

FMD Control Initiatives in Bangladesh

THE HAGUE 9-10 MARCH 2016 Report and appendices. 91 ST SESSION OF THE EXECUTIVE COMMITTEE OF THE EuFMD COMMISSION

Foot-and Mouth Disease Ecological Studies In Endemic Settings: Ongoing Studies in Vietnam and Pakistan

Changing landscape for livestock production and health in China and neighbouring countries; directions and implications for FMD management

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report. September 2017

Elements of the FMD control problem in Southern Africa: 2

Foot-and-Mouth Disease Situation Monthly Report AUGUST EuFMD

FMD activities in the North African region since the 2014/2015 epidemic

INTRODUCTION Contd. INTRODUCTION Contd. FMD VIRUS SITUATION IN NIGERIA D. D. Lazarus*., S. S. Adamu., D. Shamaki., F. O. Fasina.

SEACFMD Roadmap ( ) Yu Qiu Project Officer OIE SRR-SEA

GLOBAL FMD SITUATION DURING 2001/2002

Transcription:

WHICH VACCINES ARE MOST IMPORTANT? PRAGMATIST: A DECISION SUPPORT TOOL FOR FOOT AND MOUTH DISEASE VACCINE BANK MANAGERS Melissa McLaws 1, Don King 2, Katie Hickey 1, Anna Ludi 2, Keith Sumption 1 European Commission for the Control of Foot and Mouth Disease (EuFMD) 1 WRLFMD The Pirbright Institute 2

Key Messages PRAGMATIST is a tool to assist vaccine bank managers select /maintain the most appropriate antigens Transparent, evidence based Vaccine matching results Other applications: Highlight data gaps and important antigens that do not have a good vaccine available Framework for surveillance to engage international FMD lab/epi networks Next Steps Ongoing efforts to improve data quality User feedback

Context FMD virus: 7 serotypes, multiple strains within serotypes. No cross-protection between serotypes variable between strains within serotypes Multiple vaccine strains available FMD serotypes Viruses in any region are a potential threat to all other regions, no matter how far away, and consequently should be considered for inclusion in antigen banks. (Lombard & Füssel, 2007)

Context FMD virus: 7 serotypes, multiple strains within serotypes. No cross-protection between serotypes variable between strains within serotypes Multiple vaccine strains available Which strains are most important to maintain in my vaccine bank? Viruses in any region are a potential threat to all other regions, no matter how far away, and consequently should be considered for inclusion in antigen banks. (Lombard & Füssel, 2007)

Which strains to maintain in the vaccine bank? Significant financial investment The World Reference Laboratory produces annual recommendations Antigens divided into high, medium and low priority EU perspective: not global in nature Criteria are not clearly defined

PRAGMATIST: PRioritisation of AntiGen MAnagemenT with International Surveillance Tool EuFMD and WRL collaboration Assist risk managers make decisions about the FMD vaccines that they purchase/maintain, based on current risks to countries covered by the bank

Excel spreadsheet 2 distinct considerations: PRAGMATIST: Antigen Priority tool 1. Antigen risk score : which strains pose greatest threat of incursion (left side) and 2. Coverage score : effectiveness of available vaccines to protect against each virus strain (right side) cv cv

Antigen risk score For a given free country/region the strains that pose the greatest threat of incursion will depend on: 1. From what FMD endemic area(s) is the virus most likely to enter the country? (most likely source areas ) 2. Which virus strains are currently circulating in the source areas?

Where is the virus most likely to come from? (Source area score) Virus likely to enter due to illegal/informal activity Legal activities made safe by border and trade restrictions Main routes of incursion: 1. Infected live animals 2. FMDV-contaminated animal product 3. (Fomite, wildlife) Importance of the source area will depend on the user: ie will be different if she is in Australia vs N. America vs. Europe Expert opinion/user input Consider proximity, connectedness, incentive, prevalence

Where is the virus most likely to come from? (Source area score) Expert elicitation at European NRL meeting (May 2016) Source Area Multiplier Divide 100 points according to the risk posed by the source area W. Eurasia 41 E. Asia 11 N. Africa 25 India & S. Asia 9 East Africa 4 West/Central Af 4 Southern Africa 3 S. America 3 100

Relative prevalence of viral strains circulating within the source areas Many virus pools have 3+ serotypes circulating at once, (& multiple strains within serotypes) Relative prevalence of serotypes/strains is dynamic: population immunity (natural or vaccination) ecology of the viruses (eg new strains outcompete older strains) Data: Submissions to WRL and expert opinion

Caution: Data preliminary, For example only! Calculating the Antigen risk score Circulating Strain W. Eurasia aaaaaaaaaaaaaa ssssssssss = E. Asia N. Africa ssssssssssss aaaaaaaa nn ssssssssssss aaaaaaaa 1 India & S. Asia East Africa pppppppppppppppppppp ssssssssss ssssssssssss ssssssssss West/ Central Africa Southern Africa S. America Antigen score source area score 41 11 25 9 4 4 3 3 O/ME-SA/PanAsia-2 30 1230 0 0 5 45 0 0 0 1275 O/ME-SA/PanAsia 10 410 10 110 0 0 0 0 0 0 520 O/SEA/Mya-98 0 32 352 0 0 0 0 0 0 352 O/ME-SA/Ind2001 5 205 3 33 24 600 90 810 0 0 0 0 1648 O/EA-3 0 0 54 1350 0 28 112 20 80 84 0 1434 O/EURO-SA 0 0 0 0 0 0 0 33 99.9 99.9 O/CATHAY 0 8 88 0 0 0 0 0 0 88 A/ASIA/Sea-97 0 36 396 0 0 0 0 0 0 396 A/ASIA/Iran-05 30 1230 0 15 375 0 0 0 0 0 1605 A/ASIA/G-VII 10 410 0 5 45 0 0 0 455 A/AFRICA 0 0 2 50 0 28 112 27 108 84 0 134 A/EURO-SA 0 0 0 0 0 0 0 33 99.9 99.9 Asia-1 0 11 121 0 0 0 0 0 0 121 Asia-1 Sindh-08 13 533 0 0 0 0 0 533 SAT1 0 0 0 0 8 32 26 104 40 24 0 24 SAT 2 2 82 0 5 125 0 28 112 25 100 40 84 0 291 SAT3 0 0 0 0 8 32 2 8 20 24 0 24 C 0 0 0 0 0 0 0 33 99.9 99.9 Cumulative Score 100 100 100 100 100 100 100 99.9 300 Score adjusted for route importance 4100 1100 2500 900 400 400 300 599

Excel spreadsheet 2 distinct considerations: PRAGMATIST: Antigen Priority tool 1. Antigen risk score : which strains pose greatest threat of incursion (left side) and 2. Coverage score : effectiveness of available vaccines to protect against each virus strain (right side) cv cv

Coverage score For each combination of vaccine and field virus strain Percentage of isolates of that particular strain that match the vaccine in question Coverage Vaccine Antigen coverage score no information 0 no matching isolates 0.2 1-20% isolates match 0.4 21-40% isolates match 0.6 41-60% isolates match 0.8 61-80% isolates match 1 81-100% isolates match

SEROTYPE A MSD MSD MSD MSD MSD MSD A22 Iraq A24 Cruzeiro A-Arg/2001 A-Eritrea A-Iran 96 A-Iran-05 A-Malaysai 97 A-SAU 95 A-SAU/23/86 A-TUR/2006 A/ASIA/Sea-97 A/ASIA/Iran-05 A/ASIA/G-VII A/AFRICA A/EURO-SA 0.6 0.4 0.2 0.6 0.4 0.2 0 0.2 0.2 0.6 0.6 0.4 0.4 0.4 Caution: Data preliminary, For example only!

Putting it all together: vaccine score vvvvvvvvvvvvvv ssssssssss = vvvvvvvvvv ssssssssssss nn vvvvvvvvvv ssssssssssss 1 cccccccccccccccc ssssssssss aaaaaaaaaaaaaa ssssssssss SEROTYPE A High scores for vaccines that cover well against : Strains circulating in many areas and/or Strains in most important risky areas and/or Several different strains A/ASIA/Sea-97 A/ASIA/Iran-05 A/ASIA/G-VII A/AFRICA A/EURO-SA A22 Iraq A24 Cruzeiro A-Arg/2001 A-Eritrea A-Iran 96 A-Iran-05 A-Malaysai 97 A-SAU 95 A-SAU/23/86 A-TUR/2006 MSD MSD MSD MSD MSD MSD 0.6 0.4 0.2 0.6 0.4 0.2 0 0.2 0.2 0.6 0.6 0.4 0.4 0.4 960 0 0 375 0 533 400 0 0 1254

Key Messages PRAGMATIST is a tool to assist vaccine bank managers select /maintain the most appropriate antigens Transparent, evidence based Vaccine matching results Other applications: Highlight data gaps and important antigens that do not have a good vaccine available Framework for surveillance to engage international FMD lab/epi networks Next Steps Ongoing efforts to improve data quality User feedback

Thank you for listening!